Clinical Trial Update: A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating prazosin and cyproheptadine in adults with Alcohol Use Disorder; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Cyproheptadine (cyproheptadine)
• Prazosin (prazosin)

Snippet

Sponsor: Kinnov Therapeutics | Conditions: Alcohol Use Disorder | Phase 1 | Status: COMPLETED